Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation

被引：0
|
作者：
Marx, S.
Diener, H. -C. [2 ]
Harenberg, J.
Lip, G. [3 ]
Marder, V. [4 ]
Wehling, M.
Weiss, C. [1 ]
机构：
[1] Univ Heidelberg, Med Fac Mannheim, Dept Biometr & Stat, D-6800 Mannheim, Germany
[2] Univ Clin Essen, Dept Neurol, Essen, Germany
[3] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：815 / 815
页数：1
相关论文
共 50 条
  • [21] The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
    Shimokawa, Hiroaki
    Yamashita, Takeshi
    Uchiyama, Shinichiro
    Kitazono, Takanari
    Shimizu, Wataru
    Ikeda, Takanori
    Kamouchi, Masahiro
    Kaikita, Koichi
    Fukuda, Koji
    Origasa, Hideki
    Sakuma, Ichiro
    Saku, Keijiro
    Okumura, Yasuo
    Nakamura, Yuichiro
    Morimoto, Hideo
    Matsumoto, Naoki
    Tsuchida, Akihito
    Ako, Junya
    Sugishita, Nobuyoshi
    Shimizu, Shogo
    Atarashi, Hirotsugu
    Inoue, Hiroshi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 258 : 126 - 132
  • [22] EFFICACY AND SAFETY OF RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
    Ali, S.
    Wakefield, L. A.
    Saja, K.
    HAEMATOLOGICA, 2016, 101 : 140 - 140
  • [23] Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries
    Krejczy, Martin
    Harenberg, Job
    Marx, Svetlana
    Obermann, Konrad
    Froelich, Lutz
    Wehling, Martin
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 37 (04) : 507 - 523
  • [24] Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries
    Martin Krejczy
    Job Harenberg
    Svetlana Marx
    Konrad Obermann
    Lutz Frölich
    Martin Wehling
    Journal of Thrombosis and Thrombolysis, 2014, 37 : 507 - 523
  • [25] Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Carla Rognoni
    Monia Marchetti
    Silvana Quaglini
    Nicola Lucio Liberato
    Clinical Drug Investigation, 2014, 34 : 9 - 17
  • [26] Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Cost-Effectiveness Analysis
    Rognoni, Carla
    Marchetti, Monia
    Quaglini, Silvana
    Liberato, Nicola Lucio
    CLINICAL DRUG INVESTIGATION, 2014, 34 (01) : 9 - 17
  • [27] Comparative safety and effectiveness of standard doses of apixaban versus dabigatran, rivaroxaban, and VKAs in non-valvular atrial fibrillation patients in France: the NAXOS study
    Danchin, N.
    Steg, P. G.
    Hanon, O.
    Mahe, I.
    Belhassen, M.
    Jacoud, F.
    Nolin, M.
    Ginoux, M.
    Dalon, F.
    Lefevre, C.
    Cotte, F. E.
    Gollety, S.
    Falissard, B.
    Van Ganse, E.
    EUROPEAN HEART JOURNAL, 2019, 40 : 711 - 711
  • [28] Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population
    Amin, A.
    Keshishian, A.
    Zhang, Q.
    Dina, O.
    Dhamane, A.
    Nadkarni, A.
    Carda, E.
    Liu, X.
    Rosenblatt, L.
    Baser, O.
    Baker, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 820 - 820
  • [29] Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban
    Abdullah, Ahmad Salihin
    Tan, Hwee Pheng
    Mohd Saffian, Shamin
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2022, 29 (02): : 164 - 172
  • [30] Comparative Effectiveness of Dabigatran and Rivaroxaban versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Bengtson, Lindsay
    Chen, Lin
    MacLehose, Richard
    Lutsey, Pamela
    Alonso, Alvaro
    CIRCULATION, 2014, 130
12345